Fundraising Fox

Gordian Untangle Complex Disease

41 employees on LinkedIn · 7 known investors

Gordian Biotechnology develops therapies aimed at treating age-related diseases to extend healthy lifespan. It operates in the biotechnology and longevity space.

Investors · 7

Competitors · 1

by search overlap

Companies competing with Gordian Untangle Complex Disease for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$1.6M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Gordian Untangle Complex Disease do?
Gordian Biotechnology develops therapies aimed at treating age-related diseases to extend healthy lifespan. It operates in the biotechnology and longevity space.
Who are Gordian Untangle Complex Disease's investors?
Gordian Untangle Complex Disease's investors include age1, Fifty Years, Metaplanet, Prime Movers Lab, Streamlined Ventures, W ventures, 10x Founders.